Showing results 3 to 9 of 9
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy Journal:Cancer Research and Treatment | 2019 | 47 | ||
2016 | 103 | |||
2016 | 79 | |||
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens Journal:Breast Cancer Research and Treatment | 2021 | 25 | ||
2019 | 72 | |||
Saura, COliveira, MFeng, YHDai, MSChen, SWHurvitz, SAKim, SBMoy, BDelaloge, SGradishar, WMasuda, NPalacova, MTrudeau, MEMattson, JYap, YSV, MFDe Laurentiis, MYeh, YMChang, HTYau, TWildiers, HHaley, BFagnani, DLu, YSCrown, JLin, JTakahashi, MTakano, TYamaguchi, MFujii, TYao, BBebchuk, JKeyvanjah, KBryce, RBrufsky, AThe NALA Investigators | 2020 | 35 | ||
Reply to T. J. A. Dekker, D.-C. Mo et al, and A. Seidman et al Journal:Journal of Clinical Oncology | 2021 | 7 |